318 related articles for article (PubMed ID: 25135296)
1. VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Schneider-Hohendorf T; Rossaint J; Mohan H; Böning D; Breuer J; Kuhlmann T; Gross CC; Flanagan K; Sorokin L; Vestweber D; Zarbock A; Schwab N; Wiendl H
J Exp Med; 2014 Aug; 211(9):1833-46. PubMed ID: 25135296
[TBL] [Abstract][Full Text] [Related]
2. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
Breuer J; Korpos E; Hannocks MJ; Schneider-Hohendorf T; Song J; Zondler L; Herich S; Flanagan K; Korn T; Zarbock A; Kuhlmann T; Sorokin L; Wiendl H; Schwab N
J Neuroinflammation; 2018 Aug; 15(1):236. PubMed ID: 30134924
[TBL] [Abstract][Full Text] [Related]
3. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor.
Guezguez B; Vigneron P; Lamerant N; Kieda C; Jaffredo T; Dunon D
J Immunol; 2007 Nov; 179(10):6673-85. PubMed ID: 17982057
[TBL] [Abstract][Full Text] [Related]
4. Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling.
Rijcken EM; Laukoetter MG; Anthoni C; Meier S; Mennigen R; Spiegel HU; Bruewer M; Senninger N; Vestweber D; Krieglstein CF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G115-24. PubMed ID: 15001428
[TBL] [Abstract][Full Text] [Related]
5. Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.
Börnsen L; Christensen JR; Ratzer R; Oturai AB; Sørensen PS; Søndergaard HB; Sellebjerg F
PLoS One; 2012; 7(11):e47578. PubMed ID: 23226199
[TBL] [Abstract][Full Text] [Related]
6. PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Sathiyanadan K; Coisne C; Enzmann G; Deutsch U; Engelhardt B
Eur J Immunol; 2014 Aug; 44(8):2287-94. PubMed ID: 24740164
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
Theien BE; Vanderlugt CL; Nickerson-Nutter C; Cornebise M; Scott DM; Perper SJ; Whalley ET; Miller SD
Blood; 2003 Dec; 102(13):4464-71. PubMed ID: 12933585
[TBL] [Abstract][Full Text] [Related]
8. Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation.
Larochelle C; Lécuyer MA; Alvarez JI; Charabati M; Saint-Laurent O; Ghannam S; Kebir H; Flanagan K; Yednock T; Duquette P; Arbour N; Prat A
Ann Neurol; 2015 Jul; 78(1):39-53. PubMed ID: 25869475
[TBL] [Abstract][Full Text] [Related]
9. VLA-4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow.
White J; Krishnamoorthy S; Gupta D; Lancelot M; Moore N; Sarnaik S; Hobbs WE; Light DR; Hines P
Br J Haematol; 2016 Sep; 174(6):970-82. PubMed ID: 27291690
[TBL] [Abstract][Full Text] [Related]
10. The blood-central nervous system barriers actively control immune cell entry into the central nervous system.
Engelhardt B
Curr Pharm Des; 2008; 14(16):1555-65. PubMed ID: 18673197
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
Schwab N; Schneider-Hohendorf T; Wiendl H
Int Immunol; 2015 Jan; 27(1):47-53. PubMed ID: 25326459
[TBL] [Abstract][Full Text] [Related]
12. The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation.
Issekutz AC; Issekutz TB
J Immunol; 2002 Feb; 168(4):1934-9. PubMed ID: 11823529
[TBL] [Abstract][Full Text] [Related]
13. Rolling of Th1 cells via P-selectin glycoprotein ligand-1 stimulates LFA-1-mediated cell binding to ICAM-1.
Atarashi K; Hirata T; Matsumoto M; Kanemitsu N; Miyasaka M
J Immunol; 2005 Feb; 174(3):1424-32. PubMed ID: 15661900
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule.
Qing Z; Sandor M; Radvany Z; Sewell D; Falus A; Potthoff D; Muller WA; Fabry Z
J Neuropathol Exp Neurol; 2001 Aug; 60(8):798-807. PubMed ID: 11487054
[TBL] [Abstract][Full Text] [Related]
15. Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis.
Petersen ER; Ammitzbøll C; Søndergaard HB; Oturai AB; Sørensen PS; Nilsson AC; Börnsen L; von Essen M; Sellebjerg F
J Neuroimmunol; 2019 Dec; 337():577085. PubMed ID: 31655423
[TBL] [Abstract][Full Text] [Related]
16. In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.
Gandoglia I; Ivaldi F; Carrega P; Armentani E; Ferlazzo G; Mancardi G; Kerlero de Rosbo N; Uccelli A; Laroni A
Immunol Lett; 2017 Jan; 181():109-115. PubMed ID: 27919749
[TBL] [Abstract][Full Text] [Related]
17. CD43 Functions as an E-Selectin Ligand for Th17 Cells In Vitro and Is Required for Rolling on the Vascular Endothelium and Th17 Cell Recruitment during Inflammation In Vivo.
Velázquez F; Grodecki-Pena A; Knapp A; Salvador AM; Nevers T; Croce K; Alcaide P
J Immunol; 2016 Feb; 196(3):1305-1316. PubMed ID: 26700769
[TBL] [Abstract][Full Text] [Related]
18. Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis.
de Andrés C; Teijeiro R; Alonso B; Sánchez-Madrid F; Martínez ML; Guzmán de Villoria J; Fernández-Cruz E; Sánchez-Ramón S
PLoS One; 2012; 7(4):e34103. PubMed ID: 22496780
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil.
Blaheta RA; Leckel K; Wittig B; Zenker D; Oppermann E; Harder S; Scholz M; Weber S; Schuldes H; Encke A; Markus BH
Transpl Immunol; 1998 Dec; 6(4):251-9. PubMed ID: 10342739
[TBL] [Abstract][Full Text] [Related]
20. Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.
Pilz G; Harrer A; Oppermann K; Wipfler P; Golaszewski S; Afazel S; Haschke-Becher E; Trinka E; Kraus J
Mult Scler; 2012 Apr; 18(4):506-9. PubMed ID: 21965415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
